This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Thomas A. Barringer III, MD
Charlotte, NC

JAMA. 1988;259(2):216.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—I would like to commend Horsburgh et al¹ on their article entitled "Preventive Strategies in Sexually Transmitted Diseases for the Primary Care Physician" in the Aug 14 issue of THE JOURNAL. I would like to mention, however, that topical treatment with erythromycin and tetracycline is not definitely effective in preventing chlamydial conjunctivitis. It was interesting to note in their article that the recommendation to use erythromycin eye ointment for prevention of ophthalmia neonatorum by Chlamydia trachomatis received the highest recommendation based on one study performed by Hammerschlag et al.² Hammerschlag and colleagues recently repeated a prospective study to evaluate erythromycin, tetracycline, and silver nitrate drops for the prevention of chlamydial conjunctivitis in a somewhat larger population than in their original study. Of 118 infants born to Chlamydia-positive women, 11% who received silver nitrate, 13% who received erythromycin ointment, and 16% who received tetracycline ointment . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?